"Photosensitizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.
| Descriptor ID |
D017319
|
| MeSH Number(s) |
D27.505.954.444.600 D27.505.954.600.710
|
| Concept/Terms |
Photosensitizing Effect- Photosensitizing Effect
- Effect, Photosensitizing
- Photosensitizing Effects
- Effects, Photosensitizing
|
Below are MeSH descriptors whose meaning is more general than "Photosensitizing Agents".
Below are MeSH descriptors whose meaning is more specific than "Photosensitizing Agents".
This graph shows the total number of publications written about "Photosensitizing Agents" by people in this website by year, and whether "Photosensitizing Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 1 | 3 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 0 | 2 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 3 | 0 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 2 | 1 | 3 |
| 2014 | 2 | 1 | 3 |
| 2015 | 2 | 0 | 2 |
| 2016 | 2 | 1 | 3 |
| 2017 | 4 | 1 | 5 |
| 2018 | 3 | 1 | 4 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 1 | 2 |
| 2023 | 0 | 2 | 2 |
| 2024 | 2 | 3 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Photosensitizing Agents" by people in Profiles.
-
Eom S, Park SG, Koo Y, Noh Y, Choi C, Kim Y, Jun H, Cha C, Joo J, Kang S. In situ forming and self-crosslinkable protein hydrogels for localized cancer therapy and topical wound healing. J Control Release. 2025 Feb 10; 378:460-475.
-
Chuang AE, Tao YK, Dong SW, Nguyen HT, Liu CH. Polypyrrole/iron-glycol chitosan nanozymes mediate M1 macrophages to enhance the X-ray-triggered photodynamic therapy for bladder cancer by promoting antitumor immunity. Int J Biol Macromol. 2024 Nov; 280(Pt 4):135608.
-
Wibowo A, Jahir Khan M, Sansanaphongpricha K, Khemthong P, Laosiripojana N, Yu YS, Wu KC, Sakdaronnarong C. Carbon Dots in Photodynamic Therapy: The Role of Dopant and Solvent on Optical and Photo-Responsive Properties. Chemistry. 2024 Sep 25; 30(54):e202400885.
-
Chuang AE, Chen YL, Nguyen HT, Lu HT, Liu CH. Sequential management of burn wound healing stages through biointelligence-inspired platelet extracellular vesicle-encapsulated photodynamic diferuloylmethane. Nanoscale. 2024 Aug 29; 16(34):16089-16106.
-
Choppadandi M, Soumya K, Ghosh S, Balu A, Shingote T, Babu SS, Prasanna VS, Arumugam S, Velyutham R, Yallapu MM, Kapusetti G. Dual Functional Magnetic Nanoparticles Conjugated with Carbon Quantum Dots for Hyperthermia and Photodynamic Therapy for Cancer. Nanotheranostics. 2024; 8(4):442-457.
-
Caccavale S, Boccellino MP, Brancaccio G, Alfano R, Argenziano G. Keratolytics can replace curettage in daylight photodynamic therapy for actinic keratosis on the face/scalp: A randomized clinical trial. J Eur Acad Dermatol Venereol. 2024 Mar; 38(3):594-601.
-
Hashemi H, Asgari S, Mahmoud AM, Mehravaran S, Roberts CJ. Variability of CLMI-X parameters, zonal Kmax, and single-point Kmax in keratoconus progression. Eye (Lond). 2023 10; 37(15):3197-3202.
-
Castillo O, Mancillas J, Hughes W, Brancaleon L. Characterization of the interaction of metal-protoporphyrins photosensitizers with ?- lactoglobulin. Biophys Chem. 2023 01; 292:106918.
-
Hashemi H, Roberts CJ, Ambr?sio R, Mehravaran S, Hafezi F, Vinciguerra R, Vinciguerra P, Panahi P, Asgari S. Comparative Contralateral Randomized Clinical Trial of Standard (3 mW/cm2) Versus Accelerated (9 mW/cm2) CXL in Patients With Down Syndrome: 3-Year Results. J Refract Surg. 2022 Jun; 38(6):381-388.
-
Davis SA, Bovelle R, Han G, Kwagyan J. Corneal collagen cross-linking for bacterial infectious keratitis. Cochrane Database Syst Rev. 2020 06 17; 6:CD013001.